Mauna Kea Technologies SA (MKEAF)

USD 0.37

(0.0%)

Market Cap (In USD)

23.9 Million

Revenue (In USD)

11.02 Million

Net Income (In USD)

-3.72 Million

Avg. Volume

-

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.37-0.42
PE
-
EPS
-
Beta Value
1.397
ISIN
FR0010609263
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Alexandre Loiseau Ph.D.
Employee Count
-
Website
https://www.maunakeatech.com
Ipo Date
2013-04-15
Details
Mauna Kea Technologies SA develops and markets medical devices in Europe, the Middle East, Africa, the United States, Latin America, and Asia. The company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. Its flagship product is Cellvizio, a confocal miniprobe endomicroscopy system which provides physicians and researchers high-resolution images of tissues at the cellular level. The company was incorporated in 2000 and is headquartered in Paris, France.